News
The FreeStyle Libre GCM can monitor your glucose levels without needing a blood sample. Here’s what you should know about how to use it, where you can get it, and how it compares to other ...
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra ...
Rare disease research is vital to improve the lives of hundreds of millions of people worldwide. However, small target populations, combined with increasing drug development costs, can deter ...
France’s Sanofi – a major player in the rare disease category – is offering $30 per share for La Jolla, California-based Inhibrx, which had a closing price of just over $33 yesterday.
Advancement of Nolans Project engineering and design; Advancement of Nolans Project funding and offtake negotiations; Social and environmental studies and evaluations on the Project; and Mineral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results